Invesco Ltd. Enanta Pharmaceuticals Inc Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Invesco Ltd. holds 43,428 shares of ENTA stock, worth $224,957. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,428

Previous 43,364 0.15%

Holding current value

$224,957

Previous $562,000 19.93%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.05 - $16.54 $643 - $1,058	64 Added 0.15%	43,428 $450,000
Q2 2024 Aug 13, 2024	SELL	$11.43 - $17.02 $1,543 - $2,297	-135 Reduced 0.31%	43,364 $562,000
Q1 2024 May 14, 2024	BUY	$10.08 - $17.46 $234,531 - $406,241	23,267 Added 115.0%	43,499 $759,000
Q4 2023 Feb 12, 2024	BUY	$8.18 - $10.78 $13,627 - $17,959	1,666 Added 8.97%	20,232 $190,000
Q3 2023 Nov 13, 2023	SELL	$11.09 - $22.13 $727,027 - $1.45 Million	-65,557 Reduced 77.93%	18,566 $207,000
Q2 2023 Aug 11, 2023	SELL	$20.68 - $39.85 $4.5 Million - $8.67 Million	-217,647 Reduced 72.12%	84,123 $1.8 Million
Q1 2023 May 12, 2023	BUY	$38.82 - $54.59 $7.58 Million - $10.7 Million	195,171 Added 183.09%	301,770 $12.2 Million
Q4 2022 Feb 13, 2023	SELL	$40.77 - $53.73 $10.2 Million - $13.4 Million	-249,578 Reduced 70.07%	106,599 $4.96 Million
Q3 2022 Nov 14, 2022	SELL	$48.29 - $71.27 $6.92 Million - $10.2 Million	-143,353 Reduced 28.7%	356,177 $18.5 Million
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $6.01 Million - $12.1 Million	157,523 Added 46.06%	499,530 $23.6 Million
Q1 2022 May 16, 2022	BUY	$56.06 - $74.11 $2.92 Million - $3.87 Million	52,163 Added 18.0%	342,007 $24.3 Million
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $11.1 Million - $17.9 Million	183,676 Added 173.01%	289,844 $21.7 Million
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $7.18 Million - $10.3 Million	-174,996 Reduced 62.24%	106,168 $6.03 Million
Q2 2021 Aug 17, 2021	SELL	$43.76 - $53.11 $1.94 Million - $2.36 Million	-44,392 Reduced 13.64%	281,164 $12.4 Million
Q1 2021 May 17, 2021	SELL	$41.69 - $54.95 $9.91 Million - $13.1 Million	-237,655 Reduced 42.2%	325,556 $16.1 Million
Q4 2020 Feb 16, 2021	BUY	$41.16 - $47.47 $1.15 Million - $1.33 Million	27,996 Added 5.23%	563,211 $23.7 Million
Q3 2020 Nov 16, 2020	BUY	$43.36 - $53.53 $18.2 Million - $22.4 Million	419,312 Added 361.78%	535,215 $24.5 Million
Q2 2020 Aug 14, 2020	SELL	$46.37 - $57.58 $5.58 Million - $6.93 Million	-120,441 Reduced 50.96%	115,903 $5.82 Million
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $6.08 Million - $9.37 Million	-151,095 Reduced 39.0%	236,344 $12.2 Million
Q4 2019 Feb 14, 2020	BUY	$57.95 - $66.61 $3.33 Million - $3.83 Million	57,499 Added 17.43%	387,439 $23.9 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $1.15 Million - $1.69 Million	19,223 Added 6.19%	329,940 $19.8 Million
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $8.34 Million - $9.99 Million	-102,610 Reduced 24.83%	310,717 $26.2 Million
Q1 2019 May 15, 2019	SELL	$69.08 - $105.66 $3.15 Million - $4.82 Million	-45,629 Reduced 9.94%	413,327 $39.5 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $30 Million - $38.9 Million	458,956 New	458,956 $32.5 Million

Others Institutions Holding ENTA

# of Institutions

107

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $107M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account